Peregrine Pharmaceuticals shares owned by Barclays
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.8M | 277k | 6.51 |
| 2023-09-30 | $1.2M | 127k | 9.44 |
| 2023-06-30 | $1.7M | 120k | 13.97 |
| 2023-03-31 | $1.6M | 86k | 18.76 |
| 2022-12-31 | $2.6M | 189k | 13.77 |
| 2022-09-30 | $2.4M | 124k | 19.12 |
| 2022-06-30 | $293k | 19k | 15.27 |
| 2022-03-31 | $1.0M | 50k | 20.36 |
| 2021-12-31 | $2.3M | 79k | 29.18 |
| 2021-09-30 | $542k | 25k | 21.61 |
| 2021-06-30 | $211k | 8.2k | 25.63 |
| 2021-03-31 | $1.0M | 56k | 18.23 |
| 2020-12-31 | $210k | 18k | 11.54 |
| 2020-09-30 | $198k | 26k | 7.65 |
| 2020-06-30 | $204k | 31k | 6.57 |
| 2020-03-31 | $96k | 19k | 5.11 |
| 2019-12-31 | $430k | 56k | 7.67 |
| 2019-09-30 | $147k | 28k | 5.30 |
| 2019-06-30 | $202k | 36k | 5.59 |
| 2019-03-31 | $61k | 14k | 4.26 |
| 2018-12-31 | $0 | 110 | 0.00 |
| 2018-09-30 | $130k | 19k | 6.84 |
| 2018-06-30 | $15k | 3.7k | 4.03 |